Evidence map›Paper›PMID 39720732›Full record

ArticleFrontiers in immunology2024

Case report: Identification of a Chinese patient with

Xin Chen, Chunxue Jiang, Wenliang Song, Tingting Sun, Jingli Yan, Wei Xu, Kai You

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. T-cell subsets inClinical & translational immunology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xin Chen *Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Chunxue Jiang *Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Wenliang SongDepartment of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Tingting SunDepartment of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Jingli YanDepartment of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Wei Xu *Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Kai You *Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in the recombination-activating gene 1, a pivotal component essential for V(D)J recombination and the formation of T- and B-cell receptors, can result in autoimmune hemolytic anemia, a rare hematological condition characterized by the autoantibody-mediated destruction of red blood cells. Herein, we report the case of a 1-year-and-4-month-old girl who presented with progressively aggravated anemia, fever, and cough. Autoimmune hemolytic anemia was confirmed by bone marrow aspiration and Coombs test. During treatment, the patient experienced two episodes of severe pneumonia and respiratory failure. Next-generation metagenomic sequencing of sputum samples confirmed the presence of cytomegalovirus and

Indexed as

Anemia, Hemolytic, AutoimmuneChinaEast Asian PeopleFemaleHomeodomain ProteinsHumansInfantMutationHomeodomain ProteinsRAG-1 proteinautoimmune hemolytic anemiacase reportliterature reviewRAG1V(D)J Recombination

Identifiers

PMID39720732
PMCPMC11666426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.